Skip to content

Evaluation of the Effect of Appropriate Sedation for Patients After Abdominal Surgeries : A Prospective Randomised Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02670954
Enrollment
154
Registered
2016-02-02
Start date
2015-10-31
Completion date
2016-01-31
Last updated
2016-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sedation, Abdominal Surgery

Brief summary

To evaluate the efficacy and safety of appropriate postoperative sedation with dexmedetomidine for patients after abdominal surgeries.Prospective randomised controlled study was conducted among patients after abdominal surgeries began in October 2015.The investigators enroll patients who received abdominal surgeries. One group receive sedative along with analgesic and the other group analgesic only for the other group on the first 24 hours after surgeries and will follow up for 3 days.

Interventions

Sponsors

Chinese Medical Association
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 16-85 years old * underwent abdominal surgeries including enterectomy, gastrectomy, hepatectomy and pancreatectomy in the hospital and operation duration lasted at least 2 hours.

Exclusion criteria

* take part in other clinical trials * quinolone antibiotics intake 4 weeks prior to or within the study * NSAIDS intake within one month * history of peptic ulcer * respiratory insufficiency * renal insufficiency * acute hepatitis or severe liver disease (Child-Pugh class C) * pregnancy or lactation * abnormal ECG with clinical significance * uncontrolled hypotension * bleeding tendency or hematological diseases * untreated mechanical intestinal obstruction * unable to express or any kind of mental disease.

Design outcomes

Primary

MeasureTime frameDescription
C-reactive protein(mg/L)1-3d after abdominal surgeriesevaluation of postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after surgeries
postoperative pain1-3d after abdominal surgeriesassessed by Prince Henry Pain Scale by investigators at 8:00 am after surgeries until discharge from ICU
recovery of gastrointestinal functionfrom admission to 30 days after abdominal surgeriesassessed by time to first defecation
white blood cell count(10^9 /L)1-3d after abdominal surgeriesevaluation of postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after surgeries

Secondary

MeasureTime frameDescription
percentage of time within target sedation range1-3d after abdominal surgeriesassessed by Richmond Agitation-Sedation Scale by investigators at 8:00 am after surgeries until discharge from ICU, target range is -2 to +1
risk of hypotension requiring interventions1-3d after abdominal surgeriessystolic blood pressure \<80 mmHg or/and diastolic blood pressure \<50 mmHg is considered hypotension
risk of bradycardia requiring interventions1-3d after abdominal surgeriesheart rate \<40/min is considered bradycardia
use of opioids and use of benzodiazepins1-3d after abdominal surgeries

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026